We are live on ! Find out more
ARQT icon

Arcutis Biotherapeutics
ARQT

94 hedge funds and large institutions have $1.35B invested in Arcutis Biotherapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 44 increasing their positions, 17 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

963% more call options, than puts

Call options by funds: $3.69M | Put options by funds: $347K

267% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 6

159% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 17

21% more funds holding

Funds holding: 78 → 94 (+16)

18% more capital invested

Capital invested by funds: $1.15B → $1.35B (+$202M)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0.4% less ownership

Funds ownership: 93.91% → 93.51% (-0.4%)

Holders
94
Holders Change
+16
Holders Change %
+20.51%
% of All Funds
1.65%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
22
Increased
44
Reduced
17
Closed
6
Calls
$3.69M
Puts
$347K
Net Calls
+$3.34M
Net Calls Change
+$3.34M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$40.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$34.1M
3
SAM
Sectoral Asset Management
Quebec, Canada
+$27.4M
4
PCH
Polar Capital Holdings
United Kingdom
+$24.4M
5
Franklin Resources
Franklin Resources
California
+$20.4M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$32.8M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$13.6M
3
Goldman Sachs
Goldman Sachs
New York
-$6.35M
4
Millennium Management
Millennium Management
New York
-$4.53M
5
VC
Vivo Capital
California
-$3.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
26
Marshall Wace
United Kingdom
$4.9M +$2.83M +90,514 +115%
PVI
27
Pura Vida Investments
New York
$4.22M +$4.55M +145,744 New
TCM
28
Tekla Capital Management
Massachusetts
$3.81M +$4.11M +131,633 New
Morgan Stanley
29
Morgan Stanley
New York
$3.64M -$821K -26,298 -17%
Neuberger Berman Group
30
Neuberger Berman Group
New York
$3.46M +$3.74M +119,670 New
ACM
31
Altium Capital Management
New York
$3.3M +$1.59M +51,000 +81%
MS
32
Maven Securities
Jersey
$3.29M +$3.64M +116,728 New
Two Sigma Investments
33
Two Sigma Investments
New York
$3.26M +$2M +63,978 +131%
MWNA
34
Marshall Wace North America
New York
$2.81M +$2.38M +76,293 +369%
AA
35
ALPS Advisors
Colorado
$2.62M +$674K +21,589 +31%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$2.51M +$636K +20,374 +31%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$2.25M +$1.51M +48,300 +165%
Norges Bank
38
Norges Bank
Norway
$1.77M +$1.25M +40,000 +189%
Swiss National Bank
39
Swiss National Bank
Switzerland
$1.63M +$996K +31,900 +131%
Citigroup
40
Citigroup
New York
$1.54M +$1.5M +47,904 +883%
LCM
41
Laurion Capital Management
New York
$1.45M – – –
Rafferty Asset Management
42
Rafferty Asset Management
New York
$1.21M +$1.07M +34,130 +451%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$1.06M -$122K -3,904 -10%
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$1.01M +$744K +23,828 +213%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$1.01M +$111K +3,541 +11%
TD Asset Management
46
TD Asset Management
Ontario, Canada
$974K +$784K +25,100 +293%
Bank of America
47
Bank of America
North Carolina
$878K +$792K +25,356 +507%
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$732K – – –
SG Americas Securities
49
SG Americas Securities
New York
$659K +$711K +22,782 New
Goldman Sachs
50
Goldman Sachs
New York
$619K -$6.35M -203,368 -90%
1
2
3 4

ARQT Hedge Fund Activity: Q1 2021 in Review

94 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Arcutis Biotherapeutics (ARQT) for Q1 2021, worth a combined $1.35B — up 18% from $1.15B a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ARQT positions and 6 closed out — a net gain of 16 holders — while 44 added to existing stakes and 17 trimmed.

The largest buyer was BlackRock, adding an estimated $40.8M. The largest seller was RA Capital Management, exiting entirely with an estimated $32.8M sold.

  • 94 institutional investors held Arcutis Biotherapeutics (ARQT) as of Q1 2021, up from 78 in Q4 2020.
  • Funds reported $1.35B of Arcutis Biotherapeutics stock for Q1 2021, up 18% quarter-over-quarter.
  • 22 funds opened new Arcutis Biotherapeutics positions in Q1 2021 and 6 closed out, a net change of +16 holders.
  • The largest Arcutis Biotherapeutics buyer in Q1 2021 was BlackRock, an estimated $40.8M added.
  • The largest Arcutis Biotherapeutics seller in Q1 2021 was RA Capital Management, an estimated $32.8M sold.

Based on aggregated 13F filings for Q1 2021.